[Plasma dopamine concentrations in various types of hypertension]. 1986

M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe

The concentrations of unconjugated plasma dopamine (PDA) were studied in patients with various types of hypertension. Catecholamines were extracted from plasma specimens (1.0-3.0 ml) through an Amberlite CG50 (Li+-form) microcolumn and eluted by a magnesium sulfate - ethanol solution. The elute was then desalinated and deproteinized by the ethanol-treated precipitation procedure and dried in a vacuum oven at 25 degrees C. A fraction of catecholamines was assayed with the modified procedures of the COMT-mediated radio-enzymatic method. This assay system was sensitive enough to permit an accurate measurement of PDA as low as 6.0 pg per ml of plasma without any detectable contamination of the conjugated dopamine. The resting levels of PDA were 10.1 +/- 1.0 pg/ml (mean +/- SEM), 9.5 +/- 1.0 and 13.7 +/- 0.6 in patients with borderline hypertension (BH, n = 25), essential hypertension (EH, n = 22) and renovascular hypertension (RVH, n = 8), respectively. The values in EH patients were significantly smaller than those in age-matched normal controls (13.0 +/- 1.4, n = 14, p less than 0.05). Remarkably increased PDA values were observed in patients with pheochromocytoma (76.5 +/- 25.4, n = 9, p less than 0.01). Significantly raised PDA values were also found in patients with primary aldosteronism (PA, 27.8 +/- 9.0, n = 6, p less than 0.05), while their plasma norepinephrine levels (PNE, 169 +/- 39 pg/ml) tended to be lower than those of normal controls (206 +/- 20), showing an apparent dissociation between the values of PDA and PNE. Upright posture for 15 minutes induced a significant rise in PDA (p less than 0.05) in all subjects except PA patients. The postural changes of PDA, however, were invariably smaller than those of PNE (p less than 0.05). The resting values of PDA in normal, BH and EH patients showed a significant negative correlation with their mean arterial pressures (r = -0.301, n = 61, p less than 0.05) and a positive correlation with those of PNE (r = 0.381, p less than 0.01). There was no correlation between PDA and age in any group studied. These findings indicate that PDA might not be only a precursor fraction of neurotransmitters released from the sympathetic nervous system but could also represent a physiological function of the dopaminergic regulatory system. The varied but distinctive features of PDA status in various types of hypertension suggest the possibility that the peripheral dopaminergic mechanisms play an inherent role in the pathogenesis of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011187 Posture The position or physical attitude of the body. Postures
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
January 1989, Rinsho byori. The Japanese journal of clinical pathology,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
January 1975, Nihon Jinzo Gakkai shi,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
January 1980, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
January 1976, Horumon to rinsho. Clinical endocrinology,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
November 1972, Scandinavian journal of clinical and laboratory investigation,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
June 1994, Casopis lekaru ceskych,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
March 1986, Nihon rinsho. Japanese journal of clinical medicine,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
August 1975, Vnitrni lekarstvi,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
July 1976, Endokrinologie,
M Takahashi, and Y Miura, and N Sano, and S Kimura, and S Toriyabe, and Y Ishizuka, and H Ohashi, and T Noshiro, and T Sugawara, and H Watanabe
January 1977, Postgraduate medical journal,
Copied contents to your clipboard!